Literature DB >> 6182083

Binding and biological actions of insulin-like growth factors on human arterial smooth muscle cells.

B Pfeifle, H H Ditschuneit, H Ditschuneit.   

Abstract

Insulin-like growth factors (IGF) were isolated from human serum and compared with some biological actions of IGF supplied by Dr. J. Hapf, Zürich. Both factors were potent mitogens. They stimulated DNA-, RNA- and protein synthesis in cultivated human arterial smooth muscle cells. Furthermore, they enhanced the aminoacid transport. Our protein fraction (IGF Ulm) had a more potent biological activity than IGF (Zürich). Specific binding receptors for IGF (Zürich) on human arterial smooth muscle cells could be demonstrated. Specific binding of 125I-IGF (Zürich) was 10%. Half-maximal displacement was achieved by 250 ng/ml of unlabeled IGF (Zürich), by 1.2 micrograms/ml of IGF (Ulm), by 6.3 micrograms/ml of pro-insulin and by 17.8 micrograms/ml of insulin. In separate studies we could demonstrate that sera of normal adults, diabetic, acromegalic and hypophysectomized patients showed different growth-promoting activity in human arterial smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182083     DOI: 10.1055/s-2007-1019031

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  9 in total

1.  Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities.

Authors:  K E Bornfeldt; R A Gidlöf; A Wasteson; M Lake; A Skottner; H J Arnqvist
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

2.  Proliferative response of human and minipig smooth muscle cells after coronary angioplasty to growth factors and platelets.

Authors:  C Unterberg; T Meyer; V Wiegand; H Kreuzer; A B Buchwald
Journal:  Basic Res Cardiol       Date:  1996 Nov-Dec       Impact factor: 17.165

3.  Intimal hyperplasia: the permeation of serum-derived substance into the arterial autovein graft under abnormal blood flow.

Authors:  M Kuroki; K Okadome; K Inokuchi; K Sugimachi
Journal:  Jpn J Surg       Date:  1988-05

4.  Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells.

Authors:  S I Chisalita; H J Arnqvist
Journal:  Diabetologia       Date:  2005-08-11       Impact factor: 10.122

5.  Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells.

Authors:  K Staiger; H Staiger; M A Schweitzer; E Metzinger; B Balletshofer; H-U Häring; M Kellerer
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

6.  G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells.

Authors:  P Delafontaine; A Anwar; H Lou; L Ku
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

7.  Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts.

Authors:  F J Ballard; L C Read; G L Francis; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

8.  Involvement of insulin-like growth factor-1 and its binding proteins in proliferation and differentiation of murine bone marrow-derived macrophage precursors.

Authors:  E Long; H T Huynh; X Zhao
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

9.  Epidermal growth factor controls smooth muscle alpha-isoactin expression in BC3H1 cells.

Authors:  Y C Wang; P A Rubenstein
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.